Concepedia

Robin Ball

RB

Statistics

Publications

1

Citations

23

H-Index

1

Active since

2002

Affiliations

Developmental Studies Hybridoma Bank(Current)

Robin Ball is an author at Developmental Studies Hybridoma Bank specializing in therapy-induced growth inhibition, targeted cancer therapy, and molecular oncology.

Publications per year

2002–2002

1

Publications

1

GEM 231, a second-generation antisense agent complementary to protein kinase A RIα subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts

Sudhir Agrawal, Ekambar R. Kandimalla, Dong Yu et al. · International Journal of Oncology · 2002 · 23 citations

Medicine, Oncology, Pharmacology +15

1–1 of 1